Brian Daniels - Jun 1, 2021 Form 4/A - Amendment Insider Report for Cabaletta Bio, Inc. (CABA)

Role
Director
Signature
/s/ Steven Nichtberger, Attorney-in-Fact
Stock symbol
CABA
Transactions as of
Jun 1, 2021
Transactions value $
$0
Form type
4/A - Amendment
Date filed
6/28/2021, 04:30 PM
Date Of Original Report
Jun 3, 2021
Next filing
Jul 18, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CABA Stock Option (Right to buy) Award $0 -22K -100% $0.00* 0 Jun 1, 2021 Common Stock 22K $11.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Brian Daniels is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 This option shall vest in accordance with the following schedule: (1) 25% of the shares subject to the option shall vest on June 24, 2022 and (2) the remaining 75% of the shares subject to the option shall vest in equal quarterly installments over the next 3 years, subject to the Reporting Person's continued service relationship with the Issuer.

Remarks:

This Form 4 is being filed to amend the vesting terms of this grant. The amended vesting term is listed in Footnote #1.